Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-29 @ 2:56 PM
Study NCT ID:
NCT02960204
Status:
COMPLETED
Last Update Posted:
2022-02-11
First Post:
2016-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
Sponsor:
Histogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-29
First Submit QC Date:
None
Study First Post Date:
2016-11-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-18
Results First Submit QC Date:
None
Results First Post Date:
2022-01-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-13
Last Update Post Date:
2022-02-11
Last Update Post Date Type:
ACTUAL